Denis Johnson, CEO, explores developments in the CDMO sector and reveals how GRAM is gearing up for its latest phase...
Change is constant in the pharmaceutical industry, and companies must keep pace with regulatory requirements, technological advancements, and patient expectations....
What are the traits that redefine innovation in fill-finish partners? GRAM’s CEO and LTS device leadership come together to discuss...